Mumbai: In a bid to provide potential Covid-19 vaccine, Serum Institute of India (SII) today said that it would get a further $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million Covid-19 vaccine doses for India and other low- and middle-income countries next year.
Serum Institute of India will produce up to an additional 100 million COVID-19 vaccine doses for India and low and middle-income countries in 2021. The company made this announcement taking forward the collaboration between SII, Gavi, Vaccine Alliance and Bill & Melinda Gates Foundation.
The expansion follows August’s announcement of up to 100 million doses to be delivered by the collaboration and bringing the total now to be delivered to up to 200 million doses of vaccines
The company made this announcement taking forward the collaboration between SII, Gavi, Vaccine Alliance and Bill & Melinda Gates Foundation.
The expansion follows August’s announcement of up to 100 million doses to be delivered by the collaboration and bringing the total now to be delivered to up to 200 million doses of vaccines.
“At this stage, it is important for governments, global health and financial institutions in the public and private sector to come together in ensuring that no one is left behind in the road to recovery. This association is in line with our efforts to see that the future vaccines reaches the remotest part of the world providing full immunization coverage in a bid to contain the spread of the pandemic,” said Adar Poonawalla, CEO of Serum Institute of India.